Get the Stockscreener App
0.7821
4.12%
-0.0336
After Hours:
2.66
1.8779
+240.11%
Gt Biopharma Inc stock is traded at $0.7821, with a volume of 240.89K.
It is down -4.12% in the last 24 hours and down -41.20% over the past month.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
See More
Previous Close:
$0.8157
Open:
$0.83
24h Volume:
240.89K
Relative Volume:
1.24
Market Cap:
$2.78M
Revenue:
-
Net Income/Loss:
$-9.64M
P/E Ratio:
-0.113
EPS:
-6.9236
Net Cash Flow:
$-10.11M
1W Performance:
-2.84%
1M Performance:
-41.20%
6M Performance:
-67.41%
1Y Performance:
-62.40%
1-Day Range:
$0.78
$0.8307
1-Week Range:
$0.78
$0.85
52-Week Range:
$0.6303
$4.10
Gt Biopharma Inc Stock (GTBP) Company Profile
Name
Gt Biopharma Inc
Sector
Industry
Phone
(800) 304-9888
Address
505 MONTGOMERY STREET, SAN FRANCISCO
Compare GTBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.2999 | 4.32B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.40 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.57 | 102.27M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.3001 | 640.45M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.4175 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | ROTH MKM | Buy |
| May-24-21 | Initiated | H.C. Wainwright | Buy |
| Apr-13-21 | Initiated | B. Riley Securities | Buy |
| Mar-17-21 | Initiated | ROTH Capital | Buy |
Gt Biopharma Inc Stock (GTBP) Latest News
GT Biopharma (NASDAQ:GTBP) Lowered to Sell Rating by Wall Street Zen - Defense World
How to recover losses in GT Biopharma Inc. stock2025 Market Sentiment & Risk Managed Trade Strategies - newser.com
How to monitor GT Biopharma Inc. with trend dashboardsBear Alert & Comprehensive Market Scan Reports - newser.com
Should you hold or exit GT Biopharma Inc. nowCPI Data & Stepwise Swing Trade Plans - newser.com
Real time pattern detection on GT Biopharma Inc. stockJuly 2025 Patterns & Daily Technical Stock Forecast Reports - newser.com
Aug Patterns: Is GPMT.PRA a strong growth stockJuly 2025 Closing Moves & Verified Short-Term Plans - khodrobank.com
How to forecast GT Biopharma Inc. trends using time series2025 Market Overview & Growth Focused Investment Plans - newser.com
Quarterly Recap: Will GT Biopharma Inc benefit from government policyMarket Activity Summary & Consistent Profit Trading Strategies - خودرو بانک
What moving averages say about GT Biopharma Inc.2025 Market Outlook & Low Drawdown Momentum Trade Ideas - newser.com
Valuation Update: Is GT Biopharma Inc stock suitable for long term investing2025 Technical Overview & Weekly High Conviction Trade Ideas - khodrobank.com
What analysts say about GT Biopharma Inc stock2025 Macro Impact & Pattern Based Trade Signal System - خودرو بانک
Market Moves: Can GT Biopharma Inc outperform under higher oil pricesEarnings Miss & Technical Analysis for Trade Confirmation - khodrobank.com
AI Stocks: How correlated is GT Biopharma Inc. to the S&P500July 2025 PreEarnings & Consistent Growth Stock Picks - khodrobank.com
Aug Wrap: Is GT Biopharma Inc. in a long term uptrend2025 Retail Activity & Weekly Top Gainers Trade List - khodrobank.com
Published on: 2025-09-15 10:03:12 - newser.com
Is GT Biopharma Inc. stock bottoming outStock Surge & Risk Adjusted Buy/Sell Alerts - newser.com
Analyzing net buyer seller activity in GT Biopharma Inc.Trade Entry Summary & Reliable Volume Spike Trade Alerts - newser.com
What’s the recovery path for long term holders of GT Biopharma Inc.July 2025 Breakouts & AI Enhanced Trade Execution Alerts - newser.com
Using RSI to spot recovery in GT Biopharma Inc.Quarterly Risk Review & Weekly Top Gainers Trade List - newser.com
Published on: 2025-09-12 20:25:50 - Newser
Will GT Biopharma Inc. stock go up soonWeekly Trade Analysis & Low Volatility Stock Recommendations - Newser
Intraday pattern recognizer results for GT Biopharma Inc.Trade Analysis Summary & Stepwise Trade Signal Guides - Newser
Applying big data sentiment scoring on GT Biopharma Inc.2025 Dividend Review & Real-Time Volume Analysis Alerts - Newser
Will GT Biopharma Inc. stock recover after recent dropBull Run & Fast Momentum Entry Tips - Newser
What does recent volatility data suggest for GT Biopharma Inc.July 2025 WrapUp & Accurate Trade Setup Notifications - Newser
Is GT Biopharma Inc. stock poised for growthJuly 2025 WrapUp & Weekly Sector Rotation Insights - Newser
What recovery options are there for GT Biopharma Inc.July 2025 Institutional & Risk Controlled Daily Plans - Newser
Candlestick signals on GT Biopharma Inc. stock todayWeekly Investment Summary & Stock Timing and Entry Methods - Newser
Is GT Biopharma Inc. reversing from oversold territoryShare Buyback & Precise Trade Entry Recommendations - Newser
Signal strength of GT Biopharma Inc. stock in tech scannersJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
How high can GT Biopharma Inc. stock goJuly 2025 News Drivers & Risk Managed Investment Strategies - Newser
Is a relief rally coming for GT Biopharma Inc. holdersPortfolio Value Summary & Low Risk Entry Point Tips - Newser
Can a trend reversal in GT Biopharma Inc. lead to recovery2025 Pullback Review & Short-Term Trading Opportunity Alerts - Newser
Can GT Biopharma Inc. hit a new high this monthPortfolio Update Summary & Stepwise Entry and Exit Trade Signals - Newser
Quantitative breakdown of GT Biopharma Inc. recent move2025 Key Lessons & Risk Controlled Stock Alerts - Newser
Can technical indicators confirm GT Biopharma Inc.’s reversalMarket Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Will earnings trigger a reversal in GT Biopharma Inc.Weekly Profit Summary & Fast Gain Stock Tips - Newser
Will GT Biopharma Inc. outperform the marketBond Market & Daily Technical Forecast Reports - Newser
Does GT Biopharma Inc. fit your quant trading model2025 Trading Volume Trends & AI Driven Stock Price Forecasts - Newser
Gt Biopharma Inc Stock (GTBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):